ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

NCI Awards 41.5 Million for DES Study

February 28, 1975

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004